Filing Flows › biote (BTMD) › Q3 2026
biote (BTMD) Q3 2026 earnings results (third quarter 2026)
8-K filed Nov 4, 2026
biote (BTMD) reported revenue of $43.3M for the third quarter 2026 (Q3 2026), -10% from a year earlier and -2% from the quarter before. Operating margin was 5.7%, net earnings $407K (0.9% of revenue).
biote, Q3 2026: revenue $43.3M (-10% year over year), operating margin 5.7%, net earnings $407K, operating cash flow $3.7M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $43.3M | -2% | -10% |
| Operating profit | $2.5M | — | -70% |
| Net earnings | $407K | — | -95% |
| Operating cash flow | $3.7M | — | -74% |
| Free cash flow | $1.1M | — | -92% |
What changed
Revenue was $43.3M in Q3 2026, down 10% year over year and down 2% from the previous quarter. Product revenue was the largest line at 98% of revenue. Product revenue lost $4.4M year over year (down 9%), 95% of the total change.
Operating profit was $2.5M, a 5.7% margin (down 11.5 points year over year). Total costs grew 3% against a revenue fall of 10%. Net earnings were $407K, down 95% year over year. The effective tax rate was 58.3%.
Operating cash flow was $3.7M (down 74% year over year), 648% of net income including minority interests. Non-cash charges added back $1.0M of depreciation and amortization and $1.3M of share-based compensation. Working capital and other items added $747K. Capital expenditures of $2.6M left free cash flow of $1.1M.
Questions
What was biote's revenue in the third quarter 2026?
biote (BTMD) reported revenue of $43.3M for the third quarter 2026 (Q3 2026), -10% from a year earlier and -2% from the quarter before.
Was biote profitable in the third quarter 2026?
Operating profit was $2.5M (5.7% of revenue) and net earnings $407K.
Source: biote 8-K on SEC EDGAR.